Presentation is loading. Please wait.

Presentation is loading. Please wait.

Linking Drug Stability to Manufacturing Risk Assessment Approaches L. E. Kirsch Stability team leader.

Similar presentations


Presentation on theme: "Linking Drug Stability to Manufacturing Risk Assessment Approaches L. E. Kirsch Stability team leader."— Presentation transcript:

1 Linking Drug Stability to Manufacturing Risk Assessment Approaches L. E. Kirsch Stability team leader

2 Stability in Design Space Manufacturing stability measurements: criteria and uses 1.Rationality based on understanding of instability 2.Correlates to shelf-life 3.Correlates to risk: failure to reach desired shelf- life without exceeding critical instability target 2 Post- Manuf. Kinetic Model L t End of Expiry Manuf. Design Space Model L0D0L0D0

3 Correlation between Shelf-life and Manufacturing- stability Measurements (preliminary long term stability studies) Shelf-life estimated from linear extrapolation of room temperature stability data

4 Logistical Regression Model for Stability Risk Assessment Shelf-life = Time to 0.4 % lactam (linear extrapolation of long-term stability data) Stability failure: Shelf-life < Desired target dating (e.g. 2 years) Logistical Regression model: –probability of stability failure as a function of the manufacturing- stability measurements (L 0 and D 0, mole %) failure prob 0.00 0.25 0.50 0.75 1.00.175.200.225.250.275.300 D 0 + L 0 0 1

5 Estimated Stability Risk application of logistical regression model 5 Lab Bench Lots Intermediate Scale

6 Stability Risk Design Space Pilot scale-up gabapentin tablets using granulation drying time and compression force 6 Stability Risk (%) <= 1.250 <= 2.500 <= 3.750 <= 5.000 <= 6.250 <= 7.500 <= 8.750 <= 10.000 > 10.000 9 10 11 12 13 14 15 16 17 18 19 20 21 compress force 5001000150020002500 total drying time

7 Long-term stability Objectives 1.Demonstrate relationship between Manufacturing-related stability measurement (MSM: D 0 and L 0 ) and shelf-life 2.Demonstrate/validate solid state degradation model 3.Construct definitive “Risk-based” Design Space Models Current state –Studies underway


Download ppt "Linking Drug Stability to Manufacturing Risk Assessment Approaches L. E. Kirsch Stability team leader."

Similar presentations


Ads by Google